Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cytokinetics Inc (CYTK)  
$53.90 0.38 (0.71%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 122,563,000
Market Cap: 6.61(B)
Last Volume: 8,264,325 Avg Vol: 8,242,049
52 Week Range: $26.88 - $108.06
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 138,093 288,980 461,958 926,280
Total Sell Value $8,135,395 $19,867,810 $25,677,895 $46,442,456
Total People Sold 7 8 8 12
Total Sell Transactions 11 21 41 87
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 1115
  Page 31 of 45  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Wolff Andrew A SVP Clinical R&D, CMO   •       –      –    2012-09-04 4 D $0.76 $24,353 D/D (32,052) 66,698     -
   Wolff Andrew A SVP Clinical R&D, CMO   •       –      –    2012-09-04 4 OE $0.00 $0 D/D 87,500 98,750     -
   Cragg David SVP Human Resources   •       –      –    2012-09-04 4 D $0.76 $17,395 D/D (22,894) 56,081     -
   Cragg David SVP Human Resources   •       –      –    2012-09-04 4 OE $0.00 $0 D/D 62,500 78,975     -
   Barbari Sharon Surrey EVP, Finance & CFO   •       –      –    2012-09-04 4 D $0.76 $27,832 D/D (36,631) 83,746     -
   Barbari Sharon Surrey EVP, Finance & CFO   •       –      –    2012-09-04 4 OE $0.00 $0 D/D 100,000 120,377     -
   Eastern Capital Ltd 10% Owner   –       –       •   2012-06-20 3 IO $0.00 $0 D/D 0 14,303,071     -
   Malik Fady Ibraham SVP Research & Early DevOffice   •       –      –    2012-06-01 3 IO $0.00 $0 D/D 0 33,632     -
   Schmertzler Michael Director   –       •      –    2010-06-03 4 S $3.00 $16,146 I/I (5,382) 4,340,923     -
   Sabry James H Former Executive Chairman   –       –      –    2010-06-03 4 S $2.85 $72,936 D/D (25,000) 0     -
   Sabry James H Former Executive Chairman   –       –      –    2010-06-03 4 OE $0.58 $14,500 D/D 25,000 25,000     -
   Schmertzler Michael Director   –       •      –    2010-05-27 4 S $3.00 $172,824 I/I (57,608) 4,346,305     -
   Schmertzler Michael Director   –       •      –    2010-05-19 4 S $3.00 $48,717 I/I (16,239) 4,403,913     -
   Sabry James H Former Executive Chairman   –       –      –    2010-05-18 4 S $2.98 $75,250 D/D (25,000) 0     -
   Sabry James H Former Executive Chairman   –       –      –    2010-05-18 4 OE $0.58 $14,500 D/D 25,000 25,000     -
   Schmertzler Michael Director   –       •      –    2010-05-18 4 S $3.00 $1,243,764 I/I (414,588) 4,420,152     -
   Sabry James H Former Executive Chairman   –       –      –    2010-05-12 4 S $3.00 $30,000 D/D (10,000) 0     -
   Sabry James H Former Executive Chairman   –       –      –    2010-05-12 4 OE $1.20 $12,000 D/D 10,000 10,000     -
   Schmertzler Michael Director   –       •      –    2010-05-12 4 S $3.00 $248,214 I/I (82,738) 4,834,740     -
   Schmertzler Michael Director   –       •      –    2010-05-06 4 S $3.03 $101,341 I/I (33,446) 4,953,978     -
   Schmertzler Michael Director   –       •      –    2010-05-05 4 S $3.04 $1,222,384 I/I (402,100) 4,987,424     -
   Sabry James H Former Executive Chairman   –       –      –    2010-04-26 4 S $3.16 $31,779 D/D (10,000) 0     -
   Sabry James H Former Executive Chairman   –       –      –    2010-04-26 4 OE $1.20 $12,000 D/D 10,000 10,000     -
   Sabry James H Former Executive Chairman   –       –      –    2010-03-31 4 S $3.22 $32,321 D/D (10,000) 0     -
   Sabry James H Former Executive Chairman   –       –      –    2010-03-31 4 OE $1.20 $12,000 D/D 10,000 10,000     -
  1115 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 31 of 45
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us